Page last updated: 2024-10-16

gamma-aminobutyric acid and Dysphagia

gamma-aminobutyric acid has been researched along with Dysphagia in 4 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"This retrospective study evaluates the efficacy of gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck tumors."7.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"By using a median dose of 2700 mg/day of gabapentin, only 10% of patients required additional narcotic pain medications for adequate pain relief during the third and fourth week of treatment, despite grade 2 or higher mucositis present in 56% and 73% of the patients, respectively."7.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"Gabapentin appears promising in reducing the need for narcotic pain medication for patients with head and neck malignancies treated with IMRT and should be further evaluated prospectively in controlled clinical trials."7.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"This retrospective study evaluates the efficacy of gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck tumors."3.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"By using a median dose of 2700 mg/day of gabapentin, only 10% of patients required additional narcotic pain medications for adequate pain relief during the third and fourth week of treatment, despite grade 2 or higher mucositis present in 56% and 73% of the patients, respectively."3.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"Gabapentin appears promising in reducing the need for narcotic pain medication for patients with head and neck malignancies treated with IMRT and should be further evaluated prospectively in controlled clinical trials."3.76Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. ( Bar Ad, V; Both, S; Chalian, A; Dutta, PR; Quon, H; Weinstein, G, 2010)
"Chronic cough is often attributed to reflux, postnasal drip, or asthma."1.33Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. ( Lee, B; Woo, P, 2005)
"Cough and laryngospasm were the most common complaints."1.33Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. ( Lee, B; Woo, P, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirch, S1
Gegg, R1
Johns, MM1
Rubin, AD1
Yang, W1
McNutt, TR1
Dudley, SA1
Kumar, R1
Starmer, HM1
Gourin, CG1
Moore, JA1
Evans, K1
Allen, M1
Agrawal, N1
Richmon, JD1
Chung, CH1
Quon, H2
Bar Ad, V1
Weinstein, G1
Dutta, PR1
Chalian, A1
Both, S1
Lee, B1
Woo, P1

Other Studies

4 other studies available for gamma-aminobutyric acid and Dysphagia

ArticleYear
Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin.
    The Annals of otology, rhinology, and laryngology, 2013, Volume: 122, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Degluti

2013
Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
    Dysphagia, 2016, Volume: 31, Issue:2

    Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Deglutition Disorders; Enteral Nutrition; Fem

2016
Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy.
    Head & neck, 2010, Volume: 32, Issue:2

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Deglutition Disorders; Dose-Response Relationship,

2010
Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment.
    The Annals of otology, rhinology, and laryngology, 2005, Volume: 114, Issue:4

    Topics: Adolescent; Adult; Aged; Amines; Analgesics; Cough; Cyclohexanecarboxylic Acids; Deglutition Disorde

2005